Opsoclonus-myoclonus-ataxia syndrome in an elderly female : A video-based case report and literature review
- 1Department of Neurology, Bishan Hospital of Chongqing Medical University, Bishan, China
- 2Department of Intensive Care Unit, Bishan Hospital, Chonqqing University of Chinese Medicine, Chongqing, China.
Abstract
Rationale:: Opsoclonus-myoclonus-ataxia syndrome (OMAS) is rare in adults. Here, we report a rare case of OMAS in an elderly patient, accompanied by video documentation and a comprehensive literature review, which may offer valuable insights into the clinical features, diagnosis, and management of this condition.
Patient concerns:: An 81-year-old female was admitted with limb tremors lasting for 1 day. During the hospitalization, she developed opsoclonus, myoclonus, ataxia, behavioral changes, and sleep disturbances.
Diagnoses:: Laboratory and imaging findings were unremarkable, with no tumor detected during follow-up, supporting a diagnosis of idiopathic OMAS.
Interventions:: Immunotherapy consisted of steroids, while symptomatic treatment included clonazepam and gabapentin.
Outcomes:: The patient showed marked symptomatic improvement after immunotherapy. At two-year follow-up, there was no evidence of recurrence or malignancy.
Lessons:: In elderly patients, OMAS is extremely rare and often diagnosed and treated late. Comprehensive screening for malignancies and infectious triggers is critical. Early recognition and prompt immunotherapy improve outcomes.
Related
- Predictors of underlying neuroblastoma and neurodevelopmental outcomes in children with opsoclonus-myoclonus syndrome: a retrospective cohort study in China
- Facial pruritus and stiffness as the initial manifestations of glycine receptor antibody-positive progressive encephalomyelitis with rigidity and myoclonus: a case report and literature review
- Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome (CANVAS): A case report of RFC1-associated disease
- Paroxysmal Kinesigenic Dyskinesia and Progressive Ataxia‐Spasticity Syndrome Caused by a Biallelic Variant in KCNJ10
- Conservative management of postoperative bronchopleural fistula in elderly lung cancer patient: a case report with literature review.
BibTeX
@article{meng2026opsoclonusmyoclonusataxia,
title = {{Opsoclonus-myoclonus-ataxia syndrome in an elderly female : A video-based case report and literature review}},
author = {Chi Meng and Yan Li and Siyuan Wen and Feifei Chen and Pan Tao and Xin Kang and Jing Huang and Wei Chen and Changqing Zhou},
journal = {Medicine},
year = {2026},
month = oct,
doi = {10.1097/md.0000000000051387},
url = {https://europepmc.org/article/PMC/PMC13727239},
note = {CC BY},
}
RIS
TY - JOUR
TI - Opsoclonus-myoclonus-ataxia syndrome in an elderly female : A video-based case report and literature review
AU - Chi Meng
AU - Yan Li
AU - Siyuan Wen
AU - Feifei Chen
AU - Pan Tao
AU - Xin Kang
AU - Jing Huang
AU - Wei Chen
AU - Changqing Zhou
PY - 2026
DA - 2026/10/30
JO - Medicine
DO - 10.1097/md.0000000000051387
UR - https://europepmc.org/article/PMC/PMC13727239
AB - Rationale:: Opsoclonus-myoclonus-ataxia syndrome (OMAS) is rare in adults. Here, we report a rare case of OMAS in an elderly patient, accompanied by video documentation and a comprehensive literature review, which may offer valuable insights into the clinical features, diagnosis, and management of this condition. Patient concerns:: An 81-year-old female was admitted with limb tremors lasting for 1 day. During the hospitalization, she developed opsoclonus, myoclonus, ataxia, behavioral changes, and sleep disturbances. Diagnoses:: Laboratory and imaging findings were unremarkable, with no tumor detected during follow-up, supporting a diagnosis of idiopathic OMAS. Interventions:: Immunotherapy consisted of steroids, while symptomatic treatment included clonazepam and gabapentin. Outcomes:: The patient showed marked symptomatic improvement after immunotherapy. At two-year follow-up, there was no evidence of recurrence or malignancy. Lessons:: In elderly patients, OMAS is extremely rare and often diagnosed and treated late. Comprehensive screening for malignancies and infectious triggers is critical. Early recognition and prompt immunotherapy improve outcomes.
SN - 0304-5412
SN - 1536-5964
SN - 0025-7974
ER -